Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 8
2022 21
2023 8
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy.
Labenz C, Schleicher EM, Meineck M, Kabelitz MA, Ehrenbauer AF, Tiede A, Mauz JB, Danneberg S, Pitton MB, Steffen F, Weinmann-Menke J, Galle PR, Bittner S, Lüssi F, Marquardt JU, Maasoumy B, Gairing SJ. Labenz C, et al. Among authors: gairing sj. MedComm (2020). 2025 Nov 5;6(11):e70475. doi: 10.1002/mco2.70475. eCollection 2025 Nov. MedComm (2020). 2025. PMID: 41200277 Free PMC article.
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS.
Kabelitz MA, Gairing SJ, Tiede A, Schleicher EM, Ahl LG, Wagner L, Zucker-Reimann F, Rieland H, Mauz JB, Weinmann-Menke J, Meyer BC, Pitton MB, Wedemeyer H, Galle PR, Sandmann L, Maasoumy B, Labenz C. Kabelitz MA, et al. Among authors: gairing sj. Aliment Pharmacol Ther. 2025 Aug 1. doi: 10.1111/apt.70315. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 40751304
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.
Gairing SJ, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C, Lieb S, Sinner F, Jörg V, Fruendt T, Himmelsbach V, Abedin N, Sahin C, Böttcher K, Schuhbaur J, Labuhn S, Korolewicz J, Fulgenzi CAM, D'Alessio A, Zanuso V, Hucke F, Röhlen N, Ben Khaled N, Ramadori E, Müller L, Weinmann A, Kloeckner R, Galle PR, Tran NH, Venkatesh SK, Teufel A, Ebert M, De Toni EN, Waldschmidt DT, Marquardt JU, Bettinger D, Peck-Radosavljevic M, Geier A, Reiter FP, Rimassa L, Pinato DJ, Roderburg C, Ettrich T, Bitzer M, Scheble V, Ehmer U, Berres ML, Finkelmeier F, Gonzalez-Carmona MA, von Felden J, Schulze K, Venerito M, van Bömmel F, Jochheim LS, Pinter M, Mohr R, Ilyas SI, Schmidtmann I, Foerster F. Gairing SJ, et al. JHEP Rep. 2024 Dec 5;7(3):101295. doi: 10.1016/j.jhepr.2024.101295. eCollection 2025 Mar. JHEP Rep. 2024. PMID: 40059970 Free PMC article.
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.
Stockinger E, Luxenburger H, Bettinger D, Berlin C, Obwegs D, Sagar, Sturm L, Gromak M, Gairing SJ, Foerster F, Labenz C, MacNelly S, Boettler T, Holzner P, Bronsert P, Bengsch B, Thimme R, Hofmann M, Roehlen N. Stockinger E, et al. Among authors: gairing sj. Hepatol Commun. 2024 Oct 3;8(10):e0532. doi: 10.1097/HC9.0000000000000532. eCollection 2024 Oct 1. Hepatol Commun. 2024. PMID: 39992088 Free PMC article.
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study.
Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Dobbermann H, Sultanik P, Galle PR, Labenz J, Thabut D, Marquardt JU, Bloom PP, Lauridsen MM, Montagnese S, Labenz C. Gairing SJ, et al. JHEP Rep. 2024 Apr 26;6(8):101104. doi: 10.1016/j.jhepr.2024.101104. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39035069 Free PMC article.
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events.
Ben Khaled N, Möller M, Jochheim LS, Leyh C, Ehmer U, Böttcher K, Pinter M, Balcar L, Scheiner B, Weich A, Leicht HB, Zarka V, Ye L, Schneider J, Piseddu I, Öcal O, Rau M, Sinner F, Venerito M, Gairing SJ, Förster F, Mayerle J, De Toni EN, Geier A, Reiter FP. Ben Khaled N, et al. Among authors: gairing sj. JHEP Rep. 2024 Apr 8;6(6):101065. doi: 10.1016/j.jhepr.2024.101065. eCollection 2024 Jun. JHEP Rep. 2024. PMID: 38798717 Free PMC article.
PHES scores have limited impact on the risk of overt HE in patients with minimal HE.
Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Danneberg S, Sultanik P, Galle PR, Gioia S, Labenz J, Lok AS, Marquardt JU, Lauridsen MM, Bloom PP, Thabut D, Nardelli S, Montagnese S, Labenz C. Gairing SJ, et al. Hepatol Commun. 2024 May 3;8(5):e0438. doi: 10.1097/HC9.0000000000000438. eCollection 2024 May 1. Hepatol Commun. 2024. PMID: 38701395 Free PMC article.
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2.
Schleicher EM, Gairing SJ, Castven D, Hock CS, Dobbermann H, Heinrich S, Meineck M, Kaps L, Galle PR, Weinmann-Menke J, Nguyen-Tat M, Marquardt JU, Labenz C. Schleicher EM, et al. Among authors: gairing sj. Am J Physiol Gastrointest Liver Physiol. 2024 May 1;326(5):G583-G590. doi: 10.1152/ajpgi.00304.2023. Epub 2024 Mar 19. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38502914 Free article.
41 results